Public Health Victory: Ghana’s New HIV Infections and Mortality Rates Drop sharply in 2025
Ghana AIDS Commission reports a nearly 14% drop in AIDS-related deaths alongside declining new HIV infections, crediting expanded testing and antiretroviral treatment access.
- New HIV infections fell from 16,189 in 2024 to 13,951 in 2025
- An estimated 337,435 Ghanaians are living with HIV, including over 21,000 children under 15 and more than 33,000 young people aged 15–24.
- With sustained funding and supply chain stability, the Commission projects new annual infections could drop to ~6,430 and deaths to ~4,893 by 2030.
Ghana’s public health interventions are yielding tangible results, with new national data showing a clear downward trend in both new HIV infections and AIDS-related fatalities.
The 2025 National HIV Estimates and Projections, published by the Ghana AIDS Commission (GAC), reveals that annual new HIV transmissions decreased from 16,189 in 2024 to 13,951 in 2025. Over the same 12-month period, AIDS-related deaths fell by nearly 14%—dropping from 13,429 down to 12,051.
Presenting the data in Accra on July 20, 2026, Isaiah Doe Kwao, GAC Director for Research, Monitoring, and Evaluation, attributed the downturn to expanded access to voluntary testing, early antiretroviral therapy (ART) enrollment, and improved patient tracking.
“Ghana’s HIV response is making demonstrable progress, but reaching complete epidemic control requires sustained momentum so no population group is left behind,” Kwao stated.
Epidemiological Profile
The report outlines that an estimated 337,435 Ghanaians are currently living with HIV. A breakdown across age brackets highlights the specific demographic burden:
-
Adults (15+ years): 315,513 individuals
-
Children (Under 15): 21,922 individuals
-
Adolescents (10–19 years): 19,528 individuals
-
Youth (15–24 years): 33,317 individuals
Reflecting broader success in long-term containment, national adult prevalence (ages 15–49) has steadily retreated from 1.79% in 2015 to 1.40% in 2025.
Road to 2030: Projections and Challenges
Dr. Kharmacelle Akanbong, Director-General of the GAC, stressed that driving down new transmission rates is vital for national healthcare sustainability, as every new diagnosis adds to the long-term cost of lifetime antiretroviral care.
If testing coverage, prevention campaigns, and supply chains hold steady, the GAC projects substantial improvements by 2030:
-
New Annual Infections: Expected to drop below 6,500 per year.
-
Annual Mortality: Projected to fall under 4,900 deaths per year.
-
Adult Prevalence: Forecasted to stabilize at 1.18%.
However, GAC leadership cautioned that critical vulnerabilities persist—most notably reaching undiagnosed individuals, expanding rural testing infrastructure, and preventing stockouts of essential antiretroviral drugs. The commission called for intensified multi-stakeholder support to meet global targets to end AIDS as a public health threat by 2030.
